ReviewJournal of hypertension2021

Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding.

Jordana B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.